Related Experiment Videos
[Effect of coumermycin A1 and nalidixic acid on lambda phage integration and transducing lambdoid phages containing
Abstract:
A specific inhibitor of DNA gyrase, coumermycin A1, inhibits in vivo the interaction of bacteriophage lambda DNA and DNA of rifd transducing phages (lambda rifd47 and lambda att80 rifd35) carrying genes rpoB and rpoC of RNA polymerase. Besides, coumermycin A1 inhibits recA-dependent recombination between the bacterial region of rifd phages and a homologous region of Escherichia coli chromosome. The integration of transdusing phage DNA into the chromosome of recA host is significantly more sensitive to the inhibitory effect of coumermycin A1 than the two other processes (by one -- three orders or magnitude). Another inhibitor of DNA gyrase, nalidixic acid, does not depress the integration of both lambda and rifd phages DNA. The differential effect of coumermycin A1 on the integration of lambda and rifd phages correlates with our concept of the int-idependent mechanism of rifd phage DNA integration in recA bacteria. According to preliminary results, coumermycin A1, in contrast to its action on integration, does not inhibit the exclusion of lambda prophage from E. coli chromosome, while nalidixic acid produces a slight inhibitory effect.
Insights
Coumermycin A1, a DNA gyrase inhibitor, blocks bacteriophage DNA integration and recombination. It specifically affects rifd phage DNA integration in recA bacteria, suggesting an int-independent mechanism.
Area of Science:
- Molecular Biology
- Virology
- Genetics
Background:
- Bacteriophage DNA integration is crucial for viral replication and gene transfer.
- DNA gyrase plays a role in various DNA metabolic processes, including recombination and integration.
- The int-independent mechanism of phage DNA integration is not fully understood.
Purpose of the Study:
- To investigate the effect of DNA gyrase inhibitors on bacteriophage DNA integration and recombination.
- To elucidate the mechanism of rifd phage DNA integration in recA bacteria.
- To differentiate the roles of coumermycin A1 and nalidixic acid in phage-host DNA interactions.
Main Methods:
- In vivo studies using coumermycin A1 and nalidixic acid, specific DNA gyrase inhibitors.
- Analysis of bacteriophage lambda and rifd phage DNA interactions with Escherichia coli chromosome.
- Assessment of recA-dependent recombination and phage DNA integration in various bacterial hosts.
Main Results:
- Coumermycin A1 specifically inhibits in vivo the interaction of bacteriophage lambda and rifd phage DNA with the E. coli chromosome.
- Coumermycin A1 inhibits recA-dependent recombination between rifd phages and the E. coli chromosome.
- Rifd phage DNA integration into recA host chromosome is highly sensitive to coumermycin A1, unlike lambda phage integration.
- Nalidixic acid does not inhibit the integration of either lambda or rifd phages DNA.
- Coumermycin A1 does not inhibit lambda prophage exclusion, while nalidixic acid shows slight inhibition.
Conclusions:
- The differential effect of coumermycin A1 suggests an int-independent mechanism for rifd phage DNA integration in recA bacteria.
- DNA gyrase activity is differentially involved in various phage-host DNA metabolic processes.
- Coumermycin A1 provides a tool to study specific aspects of phage DNA integration and recombination.